免疫化学分析装置の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、稼働台数、予測（～2036年）

当レポートでは、世界の免疫化学分析装置市場について調査分析し、各地域の市場規模、主要動向、革新的な製品と技術、競合情勢などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの免疫化学分析装置と進化する競合情勢

• 主な業界動向の考察
• 免疫化学分析装置市場の各セグメントの年間収益と市場見通し（2015年～2036年）
• ユニット数、平均販売価格、市場金額に関する市場レベルのデータ

世界、地域、国レベルの各市場の考察

• 世界の動向を地域ごとに分類した定性的な各市場の情報と各国の市場の考察
• 免疫化学分析装置市場のSWOT分析
• 免疫化学分析装置市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 各国の医療制度の概要
• 各国の償還政策
• 各国の医療技術に関する規制情勢

対象企業

• Abbott Laboratories
• Roche Diagnostics International Ltd
• Siemens Healthcare Ltd
• Beckman Coulter Inc+Radiometer Medical ApS
• DiaSorin Inc
• Inova Diagnostics Inc
• bioMerieux SA
• Bio-Rad Laboratories Inc
• Quidelortho Corp
• Hologic Inc
• Quanterix Corp
• Dynex Technologies
• BioTek Instruments Inc
• Gold Standard Diagnostic, Inc.
• Revvity Inc
• Tecan US Inc
• STRATEC SE
• BMG Labtech GmbH
• その他

Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins and therapeutic drugs. Immunochemistry analyzers are typically offered in modular increments, which can operate independently or simultaneously as a unit.

Due to their versatility, immunochemistry analyzers are relied upon for the diagnosis and monitoring of a range of different conditions including diabetes, infectious disease testing, cancer diagnostics, and cardiac market tests.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Immunochemistry Analyzers and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Immunochemistry Analyzers market revenue by segment and market outlooks from 2015- 2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Immunochemistry Analyzers market.
• Competitive dynamics insights and trends provided for Immunochemistry Analyzers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Roche Diagnostics International Ltd, Siemens Healthcare Ltd, Beckman Coulter Inc+Radiometer Medical ApS, DiaSorin Inc, Inova Diagnostics Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Quidelortho Corp, Hologic Inc, Quanterix Corp, Dynex Technologies, BioTek Instruments Inc, Gold Standard Diagnostic, Inc. , Revvity Inc, Tecan US Inc, STRATEC SE, BMG Labtech GmbH and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Immunochemistry Analyzers market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Immunochemistry Analyzers market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Immunochemistry Analyzers market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Immunochemistry Analyzers market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.